Published in Virology on July 01, 1989
Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J Virol (1995) 1.18
An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J Virol (1998) 1.09
Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J Exp Med (1992) 1.07
Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. J Virol (1999) 0.96
Comparative analysis of core amino acid residues of H-2D(b)-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. J Virol (1992) 0.96
Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes. J Virol (1993) 0.96
Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants. J Virol (1990) 0.91
Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase. J Virol (2009) 0.89
Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J Virol (1995) 0.85
Why Do CD8+ T Cells become Indifferent to Tumors: A Dynamic Modeling Approach. Front Physiol (2011) 0.83
Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. J Immunol (2012) 0.83
In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice. J Virol (2004) 0.82
Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones. Virology (2007) 0.78
Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18
Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A (1991) 3.98
A T3-like protein complex associated with the antigen receptor on murine T cells. Nature (1986) 3.22
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. Science (1985) 2.78
Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature (1988) 2.56
A histidine-rich protein gene marks a linkage group favored strongly in a genetic cross of Plasmodium falciparum. Cell (1987) 2.53
Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology (1987) 2.45
Characterization of T cell receptor gamma chain expression in a subset of murine thymocytes. Science (1986) 2.40
Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol (1988) 2.38
Preventing medication errors in cancer chemotherapy. Am J Health Syst Pharm (1996) 2.33
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science (1987) 2.17
Antigen processing in vivo and the elicitation of primary CTL responses. J Immunol (1995) 2.12
Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines. Science (1987) 2.12
Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies. J Virol (1988) 2.12
Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein). Virology (1980) 2.07
Differential expression of two distinct T-cell receptors during thymocyte development. Nature (1987) 1.95
The three-dimensional dynamic geometry of the left ventricle in the conscious dog. Circ Res (1976) 1.93
The involvement of herpes simplex virus type 1 glycoproteins in cell-mediated immunity. J Immunol (1981) 1.90
Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine. J Exp Med (1986) 1.89
Plasmodium berghei: cloning of the circumsporozoite protein gene. Exp Parasitol (1987) 1.80
Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells. J Virol (1985) 1.77
Oncogenicity and cell transformation by papovavirus SV40: the role of the viral genome. Adv Cancer Res (1972) 1.73
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg (1996) 1.64
Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health Syst Pharm (1999) 1.62
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med (1990) 1.60
Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus. Proc Natl Acad Sci U S A (1984) 1.58
Intensive study and treatment of shock in man. JAMA (1967) 1.53
Two approximately 300 kilodalton Plasmodium falciparum proteins at the surface membrane of infected erythrocytes. Mol Biochem Parasitol (1988) 1.49
Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J Biol Chem (1987) 1.48
Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide. J Exp Med (1988) 1.47
Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett (1997) 1.47
Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J Virol (1987) 1.46
Classification of events with an off-site radiological impact at the Sellafield site between 1950 and 2000, using the International Nuclear Event Scale. J Radiol Prot (2006) 1.46
Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones. Virology (1993) 1.44
Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science (1985) 1.44
Radiochemical sequence analysis of biosynthetically labeled proteins. Methods Enzymol (1983) 1.43
The implications of subunit interactions for the structure of the T cell receptor-CD3 complex. Eur J Immunol (1990) 1.43
Indoor air is nearly cleanroom quality. Am J Hosp Pharm (1993) 1.40
A DNA sequence conferring high postmeiotic segregation frequency to heterozygous deletions in Saccharomyces cerevisiae is related to sequences associated with eucaryotic recombination hotspots. Mol Cell Biol (1988) 1.40
Amino acid sequence of the biotinyl subunit from transcarboxylase. J Biol Chem (1979) 1.40
Modulation of alloreactivity in transplant recipients by phenotypic manipulation of donor endothelium. J Thorac Cardiovasc Surg (1995) 1.39
Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. I. Development of cellular immunity to simian virus 40 tumor-specific transplantation antigens during tumorigenesis by transplanted cells. J Natl Cancer Inst (1973) 1.38
Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect Immun (1989) 1.38
Specificity of peptide binding by the HLA-A2.1 molecule. J Immunol (1989) 1.37
Transplantation immunity to simian virus 40-transformed cells in tumor-bearing mice. II. Evidence for macrophage participation at the effector level of tumor cell rejection. J Natl Cancer Inst (1973) 1.31
A novel linear amphipathic beta-sheet cationic antimicrobial peptide with enhanced selectivity for bacterial lipids. J Biol Chem (2001) 1.30
Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones. J Immunol (1983) 1.29
Secondary structure and location of a magainin analogue in synthetic phospholipid bilayers. Biochemistry (1996) 1.29
Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry (1997) 1.29
Thymus-dependent and thymus-independent developmental pathways for peripheral T cell receptor-gamma delta-bearing lymphocytes. J Immunol (1988) 1.29
Detection of a genome-linked protein (VPg) of hepatitis A virus and its comparison with other picornaviral VPgs. J Virol (1986) 1.29
In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J Immunol (1988) 1.29
Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology (1983) 1.28
Differential effect of adenovirus 2 E3/19K glycoprotein on the expression of H-2Kb and H-2Db class I antigens and H-2Kb- and H-2Db-restricted SV40-specific CTL-mediated lysis. Virology (1988) 1.28
An avidin monomer affinity column for the purification of biotin-containing enzymes. Anal Biochem (1979) 1.24
Peripheral murine CD3+, CD4-, CD8- T lymphocytes express novel T cell receptor gamma delta structures. J Immunol (1988) 1.23
Purification and partial characterization of an unusual protein of Plasmodium falciparum: histidine-rich protein II. Mol Biochem Parasitol (1989) 1.23
Papovavirus SV40 transplantation immunity conferred by an adenovirus-SV40 hybrid. J Natl Cancer Inst (1966) 1.23
Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res (1993) 1.23
Primary structure of the H-2Db alloantigen. II. Additional amino acid sequence information, localization of a third site of glycosylation and evidence for K and D region specific sequences. Immunogenetics (1982) 1.22
Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes. J Immunol (1989) 1.20
Polymorphism and uniparental inheritance of mitochondrial DNA in Physarum polycephalum. J Gen Microbiol (1987) 1.20
A comparison of thermoplastic obturation techniques: adaptation to the canal walls. J Endod (1997) 1.19
Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J Virol (1995) 1.18
Comparative sequence analysis of the genomic segment 6 of four rotaviruses each with a different subgroup specificity. J Gen Virol (1988) 1.18
Computer-assisted design of an implantable, intrathoracic artificial lung. Artif Organs (1994) 1.17
Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains. J Exp Med (1991) 1.17
Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin. J Biol Chem (1994) 1.16
Recombinant human IL-2 overcomes genetic nonresponsiveness to malaria sporozoite peptides. Correlation of effect with biologic activity of IL-2. J Immunol (1988) 1.14
High-efficiency purification and chemical characterization of B cell stimulatory factor-1/interleukin 4. J Immunol (1987) 1.14
Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes. J Immunol (1984) 1.14
Respiratory failure in shock. Ann Surg (1969) 1.14
Neutrophil-mediated antibody-dependent killing of herpes-simplex-virus-infected cells. Blood (1979) 1.14
Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein. J Immunol (1988) 1.13
Cryosurgical ablation of accessory atrioventricular connections: a method for correction of the pre-excitation syndrome. Circulation (1977) 1.12
Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell (1989) 1.12
Failure to find holes in the T-cell repertoire. Nature (1987) 1.12
Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysis. J Virol (1980) 1.11
Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett (1997) 1.11
Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen. Virology (1988) 1.10
Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry (1997) 1.09
Lack of relationship between virus-specific surface and transplantation antigens in hamster cells transformed by simian papovavirus SV40. J Immunol (1968) 1.09
Mammalian tyrosinase: biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc Natl Acad Sci U S A (1988) 1.09
In vivo testing of subunit vaccines against malaria sporozoites using a rodent system. Proc Natl Acad Sci U S A (1987) 1.09
Interleukin 9 promotes influx and local maturation of eosinophils. Blood (2001) 1.09
An endoplasmic reticulum-targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 large T antigen cytotoxic T-lymphocyte epitope. J Virol (1998) 1.09
Specific identification of an authentic clone for mammalian tyrosinase. J Biol Chem (1989) 1.08
Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Mol Immunol (1992) 1.08
Percutaneous catheter balloons: failure to deflate. Radiology (1985) 1.07
Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J Exp Med (1992) 1.07
Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone. J Med Chem (1972) 1.07
SV40 transplantation antigen: relationship to SV40-specific proteins. Cold Spring Harb Symp Quant Biol (1980) 1.07